CANCER

Bloodwise 8
STRATEGIC REPORT
We’ve defined five strategic goals that will accelerate
our progress in beating blood cancer.
GOAL 1: OPTIMISE PATIENT IMPACT
There are many ways we can save and improve the lives
of patients in the short, medium and long term. This
goal makes sure that we continue to prioritise and to
make robust decisions based on evidence.
GOAL 2: ACHIEVE A STEP CHANGE
IN INCOME
While goal 1 will help us to be even more effective with
the money we spend, this goal will enable us, quite
simply, to do even more. We know that if we could
double our income, there are research opportunities
and patient activities that would accelerate our
progress yet further.
GOAL 4: IMPROVE OUR REACH, REPUTATION
AND BRAND
Our success depends upon people knowing about us
and having trust and confidence in what we stand for
and achieve as an organisation. It’s therefore vitally
important that we reach many audiences, including
patients, carers, health professionals and the public, if
we’re to do all that we can to achieve our vision.
GOAL 5: STRENGTHEN THE ORGANISATION
We employ over 100 people and it’s important that we
appropriately invest in our employment policies, our
learning and development, our working environment,
the way we work and our governance to ensure that we
have a team who enjoy living their working life fully
and to the very best of their ability.
GOAL 3: LEVERAGE RESOURCE THROUGH
PARTNERSHIP
Over the years, as we’ve gained an unparalleled
knowledge of blood cancers and improved our
understanding of the needs of patients, we’ve also
recognised the important role that we can play as a
voice of authority and influence. This means that we’re
well placed to help facilitate collaborations and bring
resource to our mission that may not be recognised as
income, but is vital to accelerate progress.
Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089
Registered charity 216032 (England & Wales) SC037529 (Scotland)